130 related articles for article (PubMed ID: 19776486)
21. Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2009; 33(3 Suppl 2):75-82. PubMed ID: 19776488
[TBL] [Abstract][Full Text] [Related]
22. hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).
Carozzi FM; Iossa A; Scalisi A; Sideri M; Andersson KL; Confortini M; Del Mistro A; Maina G; Ronco G; Raggi P; Schiboni ML; Zappa M; Giorgi Rossi P
Epidemiol Prev; 2015; 39(3 Suppl 1):84-90. PubMed ID: 26405780
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
Campari C; Fedato C; Iossa A; Petrelli A; Zorzi M; Anghinoni E; Bietta C; Brachini A; Brezzi S; Cogo C; Giordano L; Giorgi D; Palazzi M; Petrella M; Schivardi MR; Visioli CB; Giorgi Rossi P;
Eur J Cancer Prev; 2016 Jul; 25(4):321-8. PubMed ID: 26207563
[TBL] [Abstract][Full Text] [Related]
24. [Cervical cancer screening with primary HPV-DNA test in the Local Health Authority 2 of Savona (Liguria Region, Northern Italy): a population-based study].
Depetrini E; Bonelli L; Ardoino S; Cirucca MC; Contin R; De Leonardis D; Errigo V; Lugani A; Franco A; Pastorino A; Carrozzi G; Venturino E
Epidemiol Prev; 2016; 40(3-4):171-8. PubMed ID: 27436250
[TBL] [Abstract][Full Text] [Related]
25. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
26. [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity].
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2012; 36(6 Suppl 1):78-86. PubMed ID: 23293272
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
28. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
29. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study.
Del Mistro A; Giorgi Rossi P; Frayle H; Pasquale L; Campari C; Ronco G; Zorzi M
BJOG; 2019 Oct; 126(11):1365-1371. PubMed ID: 31356722
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.
Del Mistro A; Frayle H; Ferro A; Callegaro S; Del Sole A; Stomeo A; Cirillo E; Fedato C; Pagni S; Barzon L; Zorzi M;
J Med Screen; 2014 Mar; 21(1):30-7. PubMed ID: 24488593
[TBL] [Abstract][Full Text] [Related]
31. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
32. National survey of the quality of 2nd level in screening for cervical cancer.
Volante R; Ronco G
Epidemiol Prev; 2006; 30(1 Suppl 3):51-7. PubMed ID: 16937846
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
34. Risk of Cervical Dysplasia After Colposcopy Care and Risk-Informed Return to Population-Based Screening: A Systematic Review.
Costa-Fagbemi M; Yakubu M; Meggetto O; Moffatt J; Walker MJ; Koné AP; Murphy KJ; Kupets R
J Obstet Gynaecol Can; 2020 May; 42(5):607-624. PubMed ID: 31679914
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer screening in Italy.
Segnan N; Ronco G; Ciatto S
Eur J Cancer; 2000 Nov; 36(17):2235-9. PubMed ID: 11072211
[TBL] [Abstract][Full Text] [Related]
36. Process performance of cervical screening programmes in Europe.
Ronco G; van Ballegooijen M; Becker N; Chil A; Fender M; Giubilato P; Kurtinaitis J; Lancucki L; Lynge E; Morais A; O'Reilly M; Sparen P; Suteu O; Rebolj M; Veerus P; Zakelj MP; Anttila A
Eur J Cancer; 2009 Oct; 45(15):2659-70. PubMed ID: 19713100
[TBL] [Abstract][Full Text] [Related]
37. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
[TBL] [Abstract][Full Text] [Related]
40. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.
Bergeron C; Giorgi-Rossi P; Cas F; Schiboni ML; Ghiringhello B; Dalla Palma P; Minucci D; Rosso S; Zorzi M; Naldoni C; Segnan N; Confortini M; Ronco G
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25568167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]